A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA

Simon Dalla Torre Di Sanguinetto, Esa Heinonen, Janine Antonov, Claus Bolte

Open source

DOI
10.1177/2168479018764660
Published
2019-01
Container
Therapeutic Innovation & Regulatory Science
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/2168479018764660,
  title = {A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA},
  author = {Simon Dalla Torre Di Sanguinetto and Esa Heinonen and Janine Antonov and Claus Bolte},
  year = {2019},
  journal = {Therapeutic Innovation \& Regulatory Science},
  doi = {10.1177/2168479018764660},
  url = {https://doi.org/10.1177/2168479018764660}
}

RIS

TY  - JOUR
TI  - A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA
AU  - Simon Dalla Torre Di Sanguinetto
AU  - Esa Heinonen
AU  - Janine Antonov
AU  - Claus Bolte
PY  - 2019
JO  - Therapeutic Innovation & Regulatory Science
DO  - 10.1177/2168479018764660
UR  - https://doi.org/10.1177/2168479018764660
ER  - 

APA

Sanguinetto, S. D. T. D., Heinonen, E., Antonov, J., & Bolte, C. (2019). A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1177/2168479018764660

Source records